Reduced efficacy of rosuvastatin by St. John's Wort.
Gordon
Ram Y
RY
Division of Cardiology, Chestnut Hill Hospital, University of Pennsylvania Health System, Philadelphia, PA, USA. ram.gordon@gmail.com
Becker
David J
DJ
Rader
Daniel J
DJ
D005464:Fluorobenzenes / Q000493:pharmacokinetics / Q000627:therapeutic use*; D041743:Herb-Drug Interactions; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D020902:Hypericum / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D028321:Plant Preparations / Q000009:adverse effects* / Q000494:pharmacology; D011743:Pyrimidines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000493:pharmacokinetics / Q000627:therapeutic use*
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D028321:Plant Preparations; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium